5 Oct 2026, 09:13
Company UpdateMS
OILOPTISCAN IMAGING LIMITED
Announcement history available from 1 August 2025
Fromto
1 Oct 2026, 14:42
Company UpdateMS
16 Sept 2026, 09:04
Director Interests—
16 Sept 2026, 08:26
Securities Administration—
16 Sept 2026, 08:25
Securities Administration—
10 Sept 2026, 08:48
Company UpdateMS
10 Sept 2026, 08:43
Director Interests—
10 Sept 2026, 08:40
Securities Administration—
9 Sept 2026, 08:26
Securities Administration—
9 Sept 2026, 08:24
Director Interests—
9 Sept 2026, 08:24
Director Interests—
1 Sept 2026, 08:21
Company UpdateMS
25 Aug 2026, 08:47
Company Administration—
25 Aug 2026, 08:47
Financial Results—
25 Aug 2026, 08:45
Financial ResultsMS
31 July 2026, 09:18
Quarterly ReportsMS
22 July 2026, 08:25
Company UpdateMS
21 July 2026, 08:33
Company UpdateMS
7 July 2026, 08:20
Company UpdateMS
4 June 2026, 08:39
Company UpdateMS
1 June 2026, 11:32
Company UpdateMS
25 May 2026, 16:11
Director Interests—
20 May 2026, 08:44
Periodic ReportsMS
30 Apr 2026, 08:47
Quarterly ReportsMS
31 Mar 2026, 09:30
Company UpdateMS
17 Mar 2026, 15:46
Substantial Holders—
25 Feb 2026, 09:51
Financial Results—
25 Feb 2026, 09:49
Financial ResultsMS
30 Jan 2026, 09:14
Quarterly ReportsMS
15 Jan 2026, 18:22
Director Interests—
15 Jan 2026, 18:14
Securities Administration—
29 Dec 2025, 13:04
Director Interests—
4 Dec 2025, 13:58
Presentations—
3 Dec 2025, 08:29
Company UpdateMS
1 Dec 2025, 15:12
Presentations—
14 Nov 2025, 15:25
Meetings & Governance—
14 Nov 2025, 10:39
Presentations—
10 Nov 2025, 11:08
Company UpdateMS
28 Oct 2025, 09:35
Quarterly ReportsMS
15 Oct 2025, 12:49
Meetings & Governance—
29 Sept 2025, 16:51
Director Interests—
24 Sept 2025, 09:41
Presentations—
23 Sept 2025, 10:53
Capital Raising—
23 Sept 2025, 10:52
Securities Administration—
19 Sept 2025, 10:50
Capital Raising—
5 Sept 2025, 12:08
Capital Raising—
5 Sept 2025, 12:07
Capital Raising—
29 Aug 2025, 15:08
Company Administration—
29 Aug 2025, 15:08
Financial Results—
29 Aug 2025, 15:05
Financial ResultsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 09:13 | Optiscan Lodges U.S. FDA 510(k) Submission for InVue | Company Update | MS | 11001 | |
| 1 Oct 2026, 14:42 | Optiscan Lodges U.S. FDA 510(k) Submission for InForm | Company Update | MS | 11001 | |
| 16 Sept 2026, 09:04 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 16 Sept 2026, 08:26 | Notification of cessation of securities - OIL | Securities Administration | — | 06027 | |
| 16 Sept 2026, 08:25 | Application for quotation of securities - OIL | Securities Administration | — | 06020 | |
| 10 Sept 2026, 08:48 | Significant Milestone Reached in ACL Digital Pathology Study | Company Update | MS | 11001 | |
| 10 Sept 2026, 08:43 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 10 Sept 2026, 08:40 | Application for quotation of securities - OIL | Securities Administration | — | 06020 | |
| 9 Sept 2026, 08:26 | Application for quotation of securities - OIL | Securities Administration | — | 06020 | |
| 9 Sept 2026, 08:24 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 9 Sept 2026, 08:24 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 1 Sept 2026, 08:21 | Optiscan Initiates Head and Neck Cancer Study in the US | Company Update | MS | 11001 | |
| 25 Aug 2026, 08:47 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 25 Aug 2026, 08:47 | 2026 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 25 Aug 2026, 08:45 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 31 July 2026, 09:18 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 22 July 2026, 08:25 | Optiscan Signs New Research Agreement for Breast Study | Company Update | MS | 11001 | |
| 21 July 2026, 08:33 | Head and Neck Study Progressing Ahead of Schedule | Company Update | MS | 11001 | |
| 7 July 2026, 08:20 | Optiscan Launches InSpecta Device for Veterinary Medicine | Company Update | MS | 11001, 12008 | |
| 4 June 2026, 08:39 | Halfway Mark Reached in Optiscan Breast Cancer Study | Company Update | MS | 11001 | |
| 1 June 2026, 11:32 | Second Anniversary of Optiscan and Mayo Clinic Agreement | Company Update | MS | 11001 | |
| 25 May 2026, 16:11 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 20 May 2026, 08:44 | Optiscan Receives $1.69m R&D Tax Refund | Periodic Reports | MS | 03014 | |
| 30 Apr 2026, 08:47 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 31 Mar 2026, 09:30 | Optiscan Submits InSpecta FDA Dossier | Company Update | MS | 11001 | |
| 17 Mar 2026, 15:46 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 25 Feb 2026, 09:51 | Half Year Report - 31 December 2025 | Financial Results | — | 03009, 03010, 03015, 03019 | |
| 25 Feb 2026, 09:49 | Appendix 4D | Financial Results | MS | 03004 | |
| 30 Jan 2026, 09:14 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 15 Jan 2026, 18:22 | Change of Director's Interest Notice x4 | Director Interests | — | 02009 | |
| 15 Jan 2026, 18:14 | Notification regarding unquoted securities - OIL | Securities Administration | — | 06021 | |
| 29 Dec 2025, 13:04 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 Dec 2025, 13:58 | Investor Presentation | Presentations | — | 03026 | |
| 3 Dec 2025, 08:29 | Optiscan Initiates Head & Neck Cancer Imaging Study | Company Update | MS | 11001 | |
| 1 Dec 2025, 15:12 | OIL Investor Webinar Invite | Presentations | — | 14014 | |
| 14 Nov 2025, 15:25 | OIL Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 14 Nov 2025, 10:39 | OIL 2025 AGM Presentation | Presentations | — | 03026, 15002 | |
| 10 Nov 2025, 11:08 | Optiscan Partners with ACL to Advance Digital Pathology | Company Update | MS | 11001 | |
| 28 Oct 2025, 09:35 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 15 Oct 2025, 12:49 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 29 Sept 2025, 16:51 | Change of Director's Interest Notice x4 | Director Interests | — | 02009 | |
| 24 Sept 2025, 09:41 | Optiscan ASX Small and Mid-Cap Conference Presentation | Presentations | — | 03026 | |
| 23 Sept 2025, 10:53 | Issue of New Shares under the Rights Issue | Capital Raising | — | 06001 | |
| 23 Sept 2025, 10:52 | Application for quotation of securities - OIL | Securities Administration | — | 06020 | |
| 19 Sept 2025, 10:50 | Rights Issue Closure and Shortfall Notification | Capital Raising | — | 06001 | |
| 5 Sept 2025, 12:08 | Letter to Ineligible Shareholders | Capital Raising | — | 06001, 16001 | |
| 5 Sept 2025, 12:07 | Optiscan Despatches Entitlement Offer Documents | Capital Raising | — | 06001 | |
| 29 Aug 2025, 15:08 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 29 Aug 2025, 15:08 | 2025 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 29 Aug 2025, 15:05 | Appendix 4E - Preliminary Final Report | Financial Results | MS | 03003 |
1–50 of 53
1 / 2